Trump budget proposal seeks to cut Medicare, Medicaid drug costs

The Trump administration’s FY19 budget proposal includes numerous provisions that are intended to cut out-of-pocket drug costs for patients, as well as government spending on drugs. Many of the proposals could only be enacted through legislation.

As expected, the proposal includes provisions that would force Medicare Part D plans to return a portion of drug company rebates to beneficiaries (see BioCentury, Feb. 9). ...